🔎 Trials Near Me

Home › Cataract › Texas

Cataract clinical trials in Texas

7 studies for Cataract are looking for participants at sites in Texas.

Cities in Texas

A Prospective, Randomized, Subject- and Examiner-Masked, Multicenter Study Comparing Bilateral Clareon TruPlus and Bilateral Clareon Monofocal Intraocular Lens Implantation (Spherical and Toric) in Cataract Subjects

  • Berkeley Eye Center - Sugar Land, Sugar Land
RecruitingPhase 4
Ages 22 and older · All sexes · Updated Jul 21, 2026 · NCT07693205

Clareon TruPlus Study

  • Berkeley Eye Center, Sugar Land
Recruiting
Ages 22 and older · All sexes · Updated Jun 3, 2026 · NCT07502456

IC-8 Apthera IOL New Enrollment Post Approval Study

  • Berkeley Eye Center, Sugar Land
RecruitingObservational study
Ages 22 and older · All sexes · Updated Jan 12, 2026 · NCT06060041

Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)

  • R and R Eye Research, LLC, San Antonio
RecruitingPhase 3
Ages 22 and older · All sexes · Updated Oct 20, 2025 · NCT07218796

Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)

  • Houston Eye Associates, Houston
RecruitingPhase 3
Ages 22 and older · All sexes · Updated Oct 20, 2025 · NCT07218783

A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects

  • Berkeley Eye Center, Houston
RecruitingPhase 4Healthy volunteers welcome
Ages 40 and older · All sexes · Updated Apr 10, 2025 · NCT06922084

Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD

  • Methodist Eye Associates | Houston Methodist, Houston
Recruiting
Ages 65 and older · All sexes · Updated Dec 3, 2024 · NCT05438732

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.